XCE Tirzepatide 5mg-60mg Wholesale Supply for Research & Pharmaceutical Use

XCE tirzepatide represents a breakthrough in dual GIP and GLP-1 receptor agonism, offering superior metabolic benefits compared to single-agonist therapies. This innovative peptide demonstrates exceptional efficacy in clinical applications, particularly for metabolic disorders and weight management.

Our XCE tirzepatide is manufactured under strict GMP conditions, ensuring pharmaceutical-grade quality with 99% purity. The compound features a precisely engineered 39-amino acid structure with strategic modifications (including Aib residues at positions 2 and 13) that enhance stability and prolong biological activity.

Key pharmacological advantages of XCE tirzepatide include:
- Dual receptor activation for enhanced glycemic control
- Extended half-life (~117 hours) for weekly dosing convenience
- Significant appetite suppression and weight loss effects
- Improved insulin sensitivity

Available in multiple dosage forms (5mg, 10mg, 15mg, 20mg, 30mg, 60mg) with custom formulations available for research institutions and pharmaceutical developers. Each batch undergoes comprehensive analytical testing including HPLC, mass spectrometry, and amino acid analysis to verify identity, purity, and potency.

Note: This product is intended for research use only. Not for human consumption or diagnostic use.